Clough Capital Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-42,800
Closed -$9.92M 135
2024
Q2
$9.92M Buy
+42,800
New +$9.3M 1.08% 37
2019
Q1
Sell
-11,485
Closed -$3.46M 132
2018
Q4
$3.46M Buy
11,485
+2,288
+25% +$730K 0.41% 70
2018
Q3
$3.25M Sell
9,197
-875
-9% -$301K 0.31% 70
2018
Q2
$2.92M Sell
10,072
-2,485
-20% -$699K 0.26% 74
2018
Q1
$3.44M Sell
12,557
-15,160
-55% -$4.71M 0.33% 71
2017
Q4
$8.83M Sell
27,717
-24,955
-47% -$8.01M 0.74% 50
2017
Q3
$16.5M Sell
52,672
-550
-1% -$163K 1.11% 30
2017
Q2
$14.4M Sell
53,222
-3,122
-6% -$826K 1% 29
2017
Q1
$15.4M Sell
56,344
-6,635
-11% -$1.88M 0.98% 30
2016
Q4
$17.9M Buy
62,979
+19,049
+43% +$5.65M 1.18% 28
2016
Q3
$13.8M Buy
+43,930
New +$13M 0.72% 50
2015
Q3
Sell
-78,386
Closed -$31.7M 200
2015
Q2
$31.7M Buy
+78,386
New +$31.5M 1.21% 23
2014
Q4
Sell
-82,130
Closed -$27.2M 180
2014
Q3
$27.2M Sell
82,130
-1,200
-1% -$396K 1.02% 35
2014
Q2
$26.3M Buy
83,330
+34,416
+70% +$10.4M 0.84% 40
2014
Q1
$15M Sell
48,914
-23,742
-33% -$7.54M 0.47% 84
2013
Q4
$20.3M Sell
72,656
-24,100
-25% -$6.23M 0.67% 55
2013
Q3
$23.3M Buy
96,756
+59,300
+158% +$13.3M 0.73% 49
2013
Q2
$8.06M Buy
+37,456
New +$8M 0.27% 121

Other funds holding BIIB